CRWV heads into the first week of July with a data set that has changed materially since the most recent note — and not in a direction that resolves the underlying tension.
A note on consistency: the July 1 article published earlier today described short interest collapsing to roughly 54,800 shares. The current snapshot shows something very different. Short interest now reads at 23.4% of the free float — 90.3 million shares as of June 30 — and is up 30% week-on-week and 50% over the past month. That earlier figure appears to have been a data anomaly. The current reading aligns with the trajectory tracked through the June 22–24 notes, which flagged shorts building persistently from 17% toward 18% and beyond. What this week's data shows is that the build continued, and then accelerated sharply in the final days of June.
The short positioning story is now the dominant one on this name. Shorts added roughly 16 million shares in the final week of June alone, pushing the position from 69 million to 90 million shares — the sharpest single-week move since the stock listed. The pace of that add is notable. Borrow availability has tightened in response, dropping from above 570% on June 26 to 311% by June 30 — still loose enough to accommodate new entrants, but moving in one direction. Cost to borrow has also climbed, rising 36% over the week to 0.62%, a one-month high. That is still inexpensive by any absolute measure, so there is no borrow squeeze underway. But the combined move — more shorts, higher borrow cost, tighter availability — points to a lending market absorbing genuine demand. The ORTEX short score ticked up to 60.7 on June 30, its highest reading of the past two weeks, consistent with the build. Options positioning adds a supportive signal for bears: the put/call ratio is running at 0.89, nearly two standard deviations above its 20-day average of 0.80, placing it near the upper end of recent readings without yet approaching the 52-week high of 1.60.
The Street, however, is not moving in the same direction as the shorts. The analyst recommendation factor ranks in the 98th percentile of the ORTEX universe — the highest-conviction bullish reading available. Rosenblatt initiated coverage last week with a Buy and a $250 target. BNP Paribas initiated at Outperform with a $192 target in early June. Cantor Fitzgerald has reiterated Overweight at $167 twice in the past month. The mean price target across the analyst community is $140, implying roughly 41% upside to the June 30 close of $99.54. The clearest dissent is DA Davidson, which downgraded to Neutral in mid-May and cut its target to $100 — essentially at-the-money. JP Morgan sits at Neutral as well, with a $105 target. So the consensus is bullish but not unanimous, and the stock has drifted 9% lower over the past month despite the positive analyst tone. The bull case rests on backlog growth and AI infrastructure demand; bears point to high debt, infrastructure capex, and competition from hyperscalers. The EV/EBITDA multiple has compressed about 9% over the past month to 7.1x, which is the market pricing in some of the bear case without fully endorsing it.
Insider activity adds another layer. Brian Venturo, co-founder and Chief Strategy Officer, sold approximately $5.3 million of stock on June 24 across multiple tranches — his second material reduction in recent weeks following a prior $7 million trim. He still holds 22.9 million shares, so these are incremental sales rather than an exit. The net insider position over the past 90 days is modestly positive at $31.8 million, largely reflecting earlier purchases by other holders. Still, the pattern of a founder trimming into a sub-$100 price is worth noting alongside the short build.
Earnings are scheduled for August 6. The last print, in early June, saw the stock fall just under 2% the next day before recovering 6% over the following week. The May 7 print was far more damaging — a 17% single-day drop that held over the subsequent five trading sessions. With short interest now at 23% of the float and rising, and the analyst community split between $100 and $250 targets, the August report is the clearest near-term event for this divergence to resolve.
See the live data behind this article on ORTEX.
Open CRWV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
